Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anfibatide in STEMI patients before PCI
NCT02495012Phase 2Unknown
- Sponsor
- Lee's Pharmaceutical Holdings Limited
- Start
- Aug 2015
- Primary completion
- Mar 2016
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of anfibatide in ST-elevation myocardial infarction (STEMI), sponsored by Lee's Pharmaceutical Holdings Limited. Status: unknown.
02
Drugs
anfibatide
03
Conditions
ST-elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02495012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02495012.